Impact of a half marathon on cellular immune system, pro-inflammatory cytokine levels, and recovery behavior of breast cancer patients in the aftercare compared to healthy controls

European Journal of Haematology

Volumn 96, Issue 2, 2016, Pages 152-159

  Zimmer, Philipp ^a   Baumann, Freerk T ^a   Bloch, Wilhelm ^a   Zopf, Eva Maria ^a   Schulz, Saskia ^a   Latsch, Joachim ^a   Schollmayer, Friederike ^a   Shimabukuro Vornhagen, Alexander ^b   von Bergwelt Baildon, Michael ^b   Schenk, Alexander ^a  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Breast cancer; Cytokines; Exercise; Immune system; Recovery

Indexed keywords

INTERLEUKIN 6; MACROPHAGE MIGRATION INHIBITION FACTOR; TUMOR NECROSIS FACTOR ALPHA; IL6 PROTEIN, HUMAN; ISOMERASE; MIF PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

ADULT; AFTERCARE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; BREAST CANCER; CANCER PATIENT; CANCER SURVIVOR; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CONVALESCENCE; CYTOTOXIC T LYMPHOCYTE; DAILY LIFE ACTIVITY; ENDURANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GRANULOCYTE; HELPER CELL; HUMAN; HUMAN CELL; INFLAMMATION; KINESIOTHERAPY; LYMPHOCYTE; MARATHON RUNNER; MEMORY T LYMPHOCYTE; MIDDLE AGED; MONOCYTE; NATURAL KILLER CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; BLOOD; BREAST TUMOR; EXERCISE; FEMALE; IMMUNOLOGY; PATHOLOGY; RUNNING;

ADULT; AFTERCARE; BREAST NEOPLASMS; EXERCISE; FEMALE; GRANULOCYTES; HUMANS; INTERLEUKIN-6; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MIDDLE AGED; MONOCYTES; PHYSICAL ENDURANCE; RUNNING; T-LYMPHOCYTE SUBSETS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84955188734     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/ejh.12561     Document Type: Article

References (34)

1. Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet 2012;380:219-29.
2. Meyerhardt JA, Giovannucci EL, Holmes MD, Chan AT, Chan JA, Colditz GA, Fuchs CS. Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol 2006;24:3527-34.
3. Boyle T, Keegel T, Bull F, Heyworth J, Fritschi L. Physical activity and risks of proximal and distal colon cancers: a systematic review and meta-analysis. J Natl Cancer Inst 2012;104:1548-61.
4. Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA. Physical activity and survival after breast cancer diagnosis. JAMA 2005;293:2479-86.
5. Kenfield SA, Stampfer MJ, Giovannucci E, Chan JM. Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study. J Clin Oncol 2011;29:726-32.
6. Schmid D, Leitzmann MF. Association between physical activity and mortality among breast cancer and colorectal cancer survivors: a systematic review and meta-analysis. Ann Oncol 2014;25:1293-311.
7. Cramp F, Byron-Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev 2012;11:CD006145.
8. Schmitz KH, Ahmed RL, Troxel A, Cheville A, Smith R, Lewis-Grant L, Bryan CJ, Williams-Smith CT, Greene QP. Weight lifting in women with breast-cancer-related lymphedema. N Engl J Med 2009;361:664-73.
9. Overgård M, Angelsen A, Lydersen S, Morkved S. Does physiotherapist-guided pelvic floor muscle training reduce urinary incontinence after radical prostatectomy? A randomized controlled trial Eur Urol 2008;54:438-48.
10. Kruijsen-Jaarsma M, Révész D, Bierings MB, Buffart LM, Takken T. Effects of exercise on immune function in patients with cancer: a systematic review. Exerc Immunol Rev 2013;19:120-43.
11. Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR. Randomized controlled trial of exercise and blood immune function in postmenopausal breast cancer survivors. J Appl Physiol (1985) 2005;98:1534-40.
12. Nieman DC, Cook VD, Suttles J, Rejeski WJ, Ribisl PM, Fragoaga OR, Nehlsen-Canarella SL. Moderate exercise training and natural killer cell cytotoxic activity in breast cancer patients. Int J Sports Med 1995;16:334-7.
13. Ladha AB, Courneya KS, Bell GJ, Field CJ, Grundy P. Effects of acute exercise on neutrophils in pediatric acute lymphoblastic leukemia survivors: a pilot study. J Pediatr Hematol Oncol 2006;28:671-7.
14. Galvão DA, Nosaka K, Taaffe DR, Peake J, Spry N, Suzuki K, Yamaha K, McGuigan MR, Kristjanson LJ, Newton RU. Endocrine and immune responses to resistance training in prostate cancer patients. Prostate Cancer Prostatic Dis 2008;11:160-5.
15. Jönsson S, Olsson B, Jacobsson S, Palmqvist L, Ricksten A, Ekeland-Sjöberg K, Wadenvik A. BCR-ABL1 transcript levels increase in peripheral blood but not in granulocytes after physical exercise in patients with chronic myeloid leukemia. Scand J Clin Lab Invest 2011;71:7-11.
16. Walsh NP, Gleeson M, Pyne DB, Nieman DC, Dhabhar FS, Shephard RJ, Oliver SJ, Bermon S, Kajeniene A. Position statement. Part two: maintaining immune health. Exerc Immunol Rev 2011;17:64-103.
17. Gómez AM, Martínez C, Fiuza-Luces C, Herrero F, Pérez M, Madero L, Ruiz JR, Lucia A, Ramírez M. Exercise training and cytokines in breast cancer survivors. Int J Sports Med 2011;32:461-7.
18. Jones LW, Fels DR, West M, et al. Modulation of circulating angiogenic factors and tumor biology by aerobic training in breast cancer patients receiving neoadjuvant chemotherapy. Cancer Prev Res (Phila) 2013;6:925-37.
19. Pedersen Petersen AM, Pedersen BK. The role of IL-6 in mediating the anti-inflammatory effects of exercise. J Physiol Pharmacol 2006;57:43-51.
20. Bower JE. Cancer-related fatigue-mechanisms, risk factors and treatments. Nat Rev Clin Oncol 2014;11:597-609.
21. Lira FS, Neto JC, Seelaender M. Exercise training as treatment in cancer cachexia. Appl Physiol Nutr Metab 2014;39:679-86.
22. Edvardsen E, Skjønsberg OH, Holme I, Nordsletten L, Borchsenius F, Anderssen SA. High-intensity training following lung cancer surgery: a randomised controlled trial. Thorax 2015;7:244-50.
23. Wenning P, Kreutz T, Schmidt A, Opitz D, Graf C, Voss S, Bloch W, Brixius K. Endurance exercise alters cellular immune status and resistin concentrations in men suffering from non-insulin-dependent Type 2 diabetes. Exp Clin Endocrinol Diabetes 2013;121:475-82.
24. McCarthy DA, Dale MM. The leucocytosis of exercise. A review and model. Sports Med 1998;6:333-63.
25. Shek PN, Sabiston BH, Buguet A, Radomski MW. Strenuous exercise and immunological changes: a multiple-time-point analysis of leukocyte subsets, CD4/CD8 ratio, immunoglobulin production and NK cell response. Int J Sports Med 1995;6:466-74.
26. Shephard RJ. Adhesion molecules, catecholamines and leucocyte redistribution during and following exercise. Sports Med 2003;33:261-84.
27. Krüger K, Mooren FC. T cell homing and exercise. Exerc Immunol Rev 2007;13:37-54.
28. Nieman DC. Immune response to heavy exertion. J Appl Physiol (1985) 1997;82:1385-94.
29. Krüger K, Lechtermann A, Fobker M, Völker K, Mooren FC. Exercise-induced redistribution of T lymphocytes is regulated by adrenergic mechanisms. Brain Behav Immun 2008;22:324-38.
30. Feuerer M, Rocha M, Bai L, Umansky V, Solomayer EF, Bastert G, Diel IJ, Schirrmacher V. Enrichment of memory T cells and other profound immunological changes in the bone marrow from untreated breast cancer patients. Int J Cancer 2001;92:96-105.
31. Perry C, Pick M, Bdolach N, Hazan-Halevi I, Kay S, Berr I, Reches A, Harishanu Y, Grisaru D. Endurance exercise diverts the balance between Th17 cells and regulatory T cells. PLoS ONE 2013;8:e74722.
32. Blat D, Zigmond E, Alteber Z, Waks T, Eshhar Z. Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells. Mol Ther 2014;22:1018-28.
33. Bergmann C. Regulatory T cells and NK cells in cancer patients. HNO 2014;62:406-14.
34. Pedersen BK, Fischer CP. Beneficial health effects of exercise-the role of IL-6 as a myokine. Trends Pharmacol Sci 2007;28:152-6.